Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-09-29Clinical Trial Update: A Phase II Exploratory Study of Iparomlimab and Tuvonralimab Combined With Chemotherapy in Neoadjuvant Treatment of HR+/HER2- Breast Cancer Patients [Phase 2]
Phase II exploratory neoadjuvant trial evaluating the combination of Iparomlimab and Tuvonralimab with chemotherapy in HR+/HER2- breast canc…
-
CLINICAL_TRIALS research · 2025-09-29Clinical Trial Update: AKT Inhibitor, Ipatasertib, With Endocrine and CDK 4/6 Inhibitor for Patients With Metastatic Breast Cancer (TAKTIC) [Phase 1]
A Phase 1 trial update evaluating the AKT inhibitor ipatasertib in combination with endocrine therapy and a CDK4/6 inhibitor for metastatic …
-
CLINICAL_TRIALS research · 2025-09-29Clinical Trial Update: Adjuvant Abemaciclib for Locoregional Recurrence of HR-positive, HER2-negative Breast Cancer (JCOG2313, AURA) [Phase 3]
A Phase 3 trial (NCT07190443) is evaluating adjuvant abemaciclib for locoregional recurrence in HR-positive, HER2-negative breast cancer; re…
-
CLINICAL_TRIALS research · 2025-09-29Clinical Trial Update: A Long-term Treatment Extension Study of Niraparib in Participants Who Completed a Prior GlaxoSmithKline/TESARO-sponsored Niraparib Study [Phase 2]
This clinical trial update describes a Phase 2 long-term treatment extension study of niraparib for participants who completed a prior GSK/T…
-
CLINICAL_TRIALS research · 2025-09-29Clinical Trial Update: Testing a Mammography Decision Intervention in a Rural Setting [NA]
A clinical trial is testing a mammography decision intervention to support screening decisions in a rural setting. Recruitment is ongoing.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-09-29Clinical Trial Update: Sacituzumab Govitecan and Intrathecal Chemotherapy for Treating Leptomeningeal Metastases From Her2-negative Breast Cancer [Phase 1, Phase 2]
A Phase 1/2 clinical trial assessing Sacituzumab Govitecan in combination with intrathecal chemotherapy for leptomeningeal metastases from H…
-
CLINICAL_TRIALS research · 2025-09-29Clinical Trial Update: Phase II Multi-center Trial Evaluating 5 Fraction Stereotactic Partial Breast Irradiation Using Gammapod [NA]
This document provides an update on a Phase II multi-center trial evaluating 5-fraction stereotactic partial breast irradiation using Gammap…
-
CLINICAL_TRIALS research · 2025-09-29Clinical Trial Update: Comparison of Outcomes of Right Internal Jugular Port Implantation in Patients With Right Versus Left Breast Cancer Undergoing Chemotherapy
This clinical trial compares outcomes of right vs left internal jugular Port-A-Cath implantation in patients with breast cancer undergoing c…
-
CLINICAL_TRIALS research · 2025-09-26Clinical Trial Update: A Study of SI-B003 or BL-B01D1+SI-B003 in Patients With Unresectable Locally Advanced or Recurrent Metastatic HER2 Negative Breast Cancer [Phase 2]
Phase 2 clinical trial evaluating SI-B003 alone or in combination with BL-B01D1 for unresectable locally advanced or recurrent metastatic HE…
-
CLINICAL_TRIALS research · 2025-09-26Clinical Trial Update: Online Mindfulness-based Stress Reduction for Patients Receiving Chemotherapy [NA]
This document provides an update on an ongoing clinical trial evaluating online mindfulness-based stress reduction for breast cancer patient…
-
CLINICAL_TRIALS research · 2025-09-26Clinical Trial Update: A Study of BL-M02D1 in Patients With Locally Advanced or Metastatic Triple Negative Breast Cancer or Other Solid Tumors [Phase 1]
This is a Phase 1 clinical trial update for BL-M02D1 in patients with locally advanced or metastatic triple-negative breast cancer and other…
-
CLINICAL_TRIALS research · 2025-09-26Clinical Trial Update: A Study of BL-M07D1 in Patients With Locally Advanced or Metastatic HER2 Positive/Low Expression Breast Cancer and Other Solid Tumors [Phase 1]
Phase 1 study investigating BL-M07D1 in patients with locally advanced or metastatic HER2-positive/low-expression breast cancer and other so…
-
CLINICAL_TRIALS research · 2025-09-26Clinical Trial Update: A Study of BL-B01D1 in Patients With Unresectable Locally Advanced or Metastatic Breast Cancer and Other Solid Tumors [Phase 1]
Phase 1 clinical trial update for BL-B01D1 in unresectable locally advanced or metastatic breast cancer and other solid tumors; recruitment …
-
CLINICAL_TRIALS research · 2025-09-25Clinical Trial Update: A Single Arm, Phase Ib/II Trial of Single Agent Pacritinib in Patients With 1q21.3 Amplified Solid Tumors Enriching for Interleukin-1 Receptor-associated Kinase 1 Pathway Activation (PAIR) [Phase 1, Phase 2]
A single-arm Phase Ib/II trial of pacritinib in 1q21.3 amplified solid tumors with IRAK1 pathway activation is described, with breast cancer…
-
CLINICAL_TRIALS research · 2025-09-25Clinical Trial Update: Adjuvant Trastuzumab Plus Neratinib in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer After Neoadjuvant Trastuzumab Plus Pertuzumab [Phase 3]
A Phase 3 clinical trial evaluating adjuvant trastuzumab plus neratinib in hormone receptor-positive, HER2-positive breast cancer after neoa…
-
CLINICAL_TRIALS research · 2025-09-25Clinical Trial Update: A Study of GR1014 Cutaneous Gel for the Prevention of Skin Reactions Caused by Radiation Therapy for Breast Cancer [Phase 2]
Phase 2 study evaluating GR1014 Cutaneous Gel to prevent radiodermatitis in patients undergoing radiation therapy for breast cancer. The tri…
-
CLINICAL_TRIALS research · 2025-09-25Clinical Trial Update: Comparison of CE-DBT and MRI in Patients With Known Breast Lesions [EARLY_Phase 1]
A clinical trial update describing a study comparing contrast-enhanced digital breast tomosynthesis (CE-DBT) and MRI in patients with known …
-
CLINICAL_TRIALS research · 2025-09-24Clinical Trial Update: Study to Determine Absorption, Metabolism, and Excretion of [14C]-SAR439859, and to Assess Absolute Oral Bioavailability of Amcenestrant (SAR439859), in Healthy Post-menopausal Women [Phase 1]
A Phase 1 clinical trial update studying the absorption, metabolism, excretion, and absolute oral bioavailability of amcenestrant (SAR439859…
-
CLINICAL_TRIALS research · 2025-09-24Clinical Trial Update: AI-based pCR Assessment/Prediction in HER2-Positive BC Using PET/MRI
An ongoing clinical trial evaluating AI-based assessment and prediction of pathologic complete response in HER2-positive breast cancer using…
-
CLINICAL_TRIALS research · 2025-09-24Clinical Trial Update: Abemaciclib and Endocrine Therapy in Older Patients With Breast Cancer. [Phase 2]
A Phase 2 clinical trial evaluating abemaciclib in combination with endocrine therapy for older patients with breast cancer is currently rec…
-
CLINICAL_TRIALS research · 2025-09-24Clinical Trial Update: 18F-FDG Versus 68Ga-FAPI-46 as PET Tracer in ER-positive Breast Cancer. [Phase 2]
Phase 2 clinical trial comparing 18F-FDG and 68Ga-FAPI-46 PET tracers in ER-positive breast cancer, currently recruiting.
-
CLINICAL_TRIALS research · 2025-09-24Clinical Trial Update: Pyrotinib Maleate Tablets in Combination With Dalpiciclib Isethionate Tablets and Standard Endocrine Therapy [Phase 1, Phase 2]
This clinical trial update summarizes phase 1/2 testing of Pyrotinib plus Dalpiciclib isethionate with standard endocrine therapy for locall…
-
CLINICAL_TRIALS research · 2025-09-24Clinical Trial Update: Acupuncture for Anxiety/Depression in Patients With Breast Cancer [NA]
A clinical trial evaluating acupuncture for anxiety and depression in patients with breast cancer is currently not recruiting.
-
CLINICAL_TRIALS research · 2025-09-24Clinical Trial Update: Evaluation of the Acceptability, Appropriateness, and Feasibility/Usability of a Metastatic Breast-cancer Specific Prognostic Calculator Among Clinicians
An update on a study evaluating the acceptability, appropriateness, and usability of a prognostic calculator specifically for metastatic bre…
-
CLINICAL_TRIALS research · 2025-09-24Clinical Trial Update: Development of a New Remote Monitoring Model for Patients With HR+HER2- Breast Cancer in Treatment With CDK4/6 Inhibitors and Hormone Therapy
A clinical trial update describes the development of a remote monitoring model for patients with HR-positive, HER2-negative breast cancer tr…